Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
05/24/2007 | WO2007058581A1 Novel 2-aminopyrimidine derivatives and their use |
05/24/2007 | WO2007058580A1 Novel 2-aminopyrimidinone derivatives and their use |
05/24/2007 | WO2007057447A1 Novel quinazoline derivatives and their medical use |
05/24/2007 | WO2007056955A1 Pyrazolopyrimidinone derivatives, their preparation and their use |
05/24/2007 | WO2006138304A3 Pyrimidine compounds |
05/24/2007 | WO2006071960A3 Compositions and methods of treating cell proliferation disorders |
05/24/2007 | US20070117980 Manganese dioxide catalyst for the hydrolysis of carbonitriles |
05/24/2007 | US20070117818 Pyrimidinone compounds useful as kinase inhibitors |
05/24/2007 | US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders |
05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
05/24/2007 | CA2629831A1 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
05/24/2007 | CA2629814A1 Bisamide inhibitors of hedgehog signaling |
05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
05/23/2007 | EP1786823A1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
05/23/2007 | EP1786783A1 Synthesis of 2,4-pyrimidinediamine compounds |
05/23/2007 | EP1786782A2 Bisaryl-sulfonamides |
05/23/2007 | EP1786781A2 Pyrimidine derivatives |
05/23/2007 | EP1480679B1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
05/23/2007 | CN1968937A Pyrimidin-4-one derivatives and their use as P38 kinase modulators |
05/23/2007 | CN1968931A Pyridine analogs as C5A antagonists |
05/23/2007 | CN1968930A Bicyclic, nitrogen-containing heterocycles aromatase inhibitors |
05/22/2007 | US7220783 Para-terphenyl compounds |
05/22/2007 | US7220777 Lactam derivatives as antagonists for human 11cby receptors |
05/22/2007 | US7220751 E.g., Cis-4-amino-cis-2-methyl-N-(6-methyl-2-(2-(2-pyridyl) ethenyl) quinazolin-4-yl)cyclohexylamine trihydrochloride; a nociceptin opiod-receptor agonist or antagonist effecting chronic pain and allodynia accompanied with herpes zoster |
05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
05/22/2007 | US7220747 Selected from the group consisting of alloxazines and photosensitizers |
05/22/2007 | US7220736 Pyrimidine compounds |
05/22/2007 | CA2368347C Glucokinase activators |
05/22/2007 | CA2276694C New fatty acid derivatives |
05/22/2007 | CA2266050C Piperazine derivatives |
05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
05/18/2007 | WO2007056151A2 Protein kinase inhbitors |
05/18/2007 | WO2007055514A1 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof |
05/18/2007 | WO2007055513A1 Quinazoline derivatives as a signal transduction inhibitor and method for the preparation thereof |
05/18/2007 | WO2007055170A1 Nucleic acid base having perfluoroalkyl group and method for producing the same |
05/18/2007 | WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
05/18/2007 | WO2006125555A3 Quinazolinones |
05/18/2007 | CA2631129A1 Nucleobase having perfluoroalkyl group and process for producing the same |
05/18/2007 | CA2628441A1 Compounds for modulating trpv3 function |
05/18/2007 | CA2627857A1 Aminopyrimidines useful as kinase inhibitors |
05/18/2007 | CA2627808A1 Aminopyrimidines useful as kinase inhibitors |
05/18/2007 | CA2626897A1 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
05/18/2007 | CA2626479A1 Protein kinase inhibitors |
05/17/2007 | US20070111999 P-38 kinase inhibitors |
05/16/2007 | EP1784399A2 Pyrimidine derivatives |
05/16/2007 | EP1784393A1 Quinazolines useful as modulators of ion channels |
05/16/2007 | EP1784392A2 Pyrimidine derivatives |
05/16/2007 | CN1964954A 吡唑并嘧啶类 Pyrazolo pyrimidine |
05/16/2007 | CN1962644A PI3K enzyme inhibitor-5-(3-amino-benzene) methyl nicotinate analog |
05/16/2007 | CN1962643A Preparation process of key intermediate 2-cyano pyrimidine of bosentan |
05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
05/16/2007 | CN1315811C Pyrimidine derivatives and preparing method thereof |
05/15/2007 | US7217844 Useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell; reduced side effects |
05/15/2007 | US7217728 For therapy of reperfusion injury |
05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
05/15/2007 | US7217712 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors |
05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
05/10/2007 | WO2007053452A1 Bi-aryl meta-pyrimidine inhibitors of kinases |
05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
05/10/2007 | WO2007002701A3 Anti-inflammatory aryl nitrile compounds |
05/10/2007 | WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
05/10/2007 | WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
05/10/2007 | WO2006066044A3 Processes for producing 4-aminoquinazolines |
05/10/2007 | US20070105882 Polymorphic forms of a known antihyperlipemic agent |
05/10/2007 | US20070105881 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
05/10/2007 | US20070105873 2-Substituted pyrimidines |
05/10/2007 | US20070105839 2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
05/10/2007 | CA2628283A1 Bi-aryl meta-pyrimidine inhibitors of kinases |
05/09/2007 | EP1783118A2 Preparation of risperidone |
05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
05/09/2007 | EP1782689A1 Optically active phthalamide derivative, agricultural or horticultural insecticide, and method of using the same |
05/09/2007 | EP1781674A1 Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer |
05/09/2007 | EP1781652A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
05/09/2007 | EP1781624A2 A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
05/09/2007 | EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors |
05/09/2007 | EP1781622A2 Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
05/09/2007 | EP1781614A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
05/09/2007 | EP1781296A2 Quinazoline derivatives and their use in the treatment of thrombocythemia |
05/09/2007 | EP1781294A2 Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
05/09/2007 | EP1597238B1 Hiv replication inhibiting pyrimidines and triazines |
05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
05/09/2007 | EP1313712B1 Process and intermediates for preparing retroviral protease inhibitors |
05/09/2007 | EP1272477B1 Pyrimidine compounds |
05/09/2007 | EP1036078B1 Thienopyrimidines |
05/09/2007 | CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors |
05/09/2007 | CN1960977A Quinazoline derivative |
05/09/2007 | CN1958593A Method for preparing intermediate of synthesizing rosuvastatin calcium |
05/09/2007 | CN1314686C Synthesis method of 2-amino-6-methyl-5-oxo-4-normal propyl-5-triazole [1,5-alpha] pyrimidine |
05/09/2007 | CN1314682C Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
05/08/2007 | US7214794 Capable of crossing cell membrane; induction apoptosis in human cancer cells |
05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
05/08/2007 | US7214518 For therapy of diseases of cell proliferation |
05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
05/08/2007 | CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
05/03/2007 | WO2007050980A2 Process for preparing mesylate salts of il-12 inhibitory compounds |